3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Motor Activity
1
Interventions
Exercise
6
pembrolizumab
1
cemiplimab
1
beta-Glucans
1
avelumab
1
Tablets
1
Surveys and Questionnaires
1
Roflumilast
1
Nivolumab
1
Nadolol
1
Isoproterenol
1
Ipilimumab
1
Immune Checkpoint Inhibitors
1
Carvedilol
1
Bisoprolol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Motor Activity
×
beta-Glucans
×
Clear all
NCT07305259
2025-12-26
REACT
Florida State University
Phase EARLY_PHASE1
Recruiting
60 enrolled